Go Pro
→ A $382 trillion migration and the position no one is talking about (From Awesomely) (Ad)tc pixel Free SINT Stock Alerts

Sintx Technologies (SINT) Competitors

Sintx Technologies logo
$1.55 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern
Compare

SINT vs. DRTSW, BDMDW, COCHW, HSCSW, and BEATW

Should you buy Sintx Technologies stock or one of its competitors? Sintx Technologies's main competitors and comparable companies include Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), Envoy Medical (COCHW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sintx Technologies compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership.

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sintx Technologies has a consensus price target of $9.33, suggesting a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Sintx Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Sintx Technologies' average media sentiment score of 0.50 beat Alpha Tau Medical's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Sintx Technologies Positive

Alpha Tau Medical has higher earnings, but lower revenue than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Sintx Technologies$1.02M6.56-$10.36M-$4.91N/A

Alpha Tau Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Alpha Tau Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Sintx Technologies -848.20%-354.44%-115.37%

Summary

Sintx Technologies beats Alpha Tau Medical on 7 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to Baird Medical Investment?

Sintx Technologies (NASDAQ:SINT) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability and valuation.

Baird Medical Investment has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Baird Medical Investment's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-848.20% -354.44% -115.37%
Baird Medical Investment N/A N/A N/A

Baird Medical Investment has higher revenue and earnings than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M6.56-$10.36M-$4.91N/A
Baird Medical Investment$22.54MN/AN/AN/AN/A

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sintx Technologies currently has a consensus target price of $9.33, indicating a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Sintx Technologies is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Baird Medical Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Sintx Technologies' average media sentiment score of 0.50 beat Baird Medical Investment's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Sintx Technologies Positive
Baird Medical Investment Neutral

Summary

Sintx Technologies beats Baird Medical Investment on 6 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to Envoy Medical?

Sintx Technologies (NASDAQ:SINT) and Envoy Medical (NASDAQ:COCHW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Envoy Medical has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Envoy Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-848.20% -354.44% -115.37%
Envoy Medical N/A N/A N/A

In the previous week, Sintx Technologies' average media sentiment score of 0.50 beat Envoy Medical's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Sintx Technologies Positive
Envoy Medical Neutral

Sintx Technologies presently has a consensus target price of $9.33, indicating a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe Sintx Technologies is more favorable than Envoy Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Envoy Medical has lower revenue, but higher earnings than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M6.56-$10.36M-$4.91N/A
Envoy Medical$207KN/AN/AN/AN/A

Summary

Sintx Technologies beats Envoy Medical on 7 of the 10 factors compared between the two stocks.

How does Sintx Technologies compare to Heart Test Laboratories?

Sintx Technologies (NASDAQ:SINT) and Heart Test Laboratories (NASDAQ:HSCSW) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

Heart Test Laboratories has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. Heart Test Laboratories' return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Sintx Technologies-848.20% -354.44% -115.37%
Heart Test Laboratories N/A N/A N/A

18.4% of Sintx Technologies shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Heart Test Laboratories had 2 more articles in the media than Sintx Technologies. MarketBeat recorded 2 mentions for Heart Test Laboratories and 0 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.50 beat Heart Test Laboratories' score of 0.45 indicating that Sintx Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Sintx Technologies Positive
Heart Test Laboratories Neutral

Heart Test Laboratories has lower revenue, but higher earnings than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sintx Technologies$1.02M6.56-$10.36M-$4.91N/A
Heart Test Laboratories$4.32KN/AN/AN/AN/A

Sintx Technologies currently has a consensus price target of $9.33, suggesting a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Sintx Technologies is more favorable than Heart Test Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Heart Test Laboratories
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Sintx Technologies beats Heart Test Laboratories on 7 of the 11 factors compared between the two stocks.

How does Sintx Technologies compare to HeartBeam?

HeartBeam (NASDAQ:BEATW) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

18.4% of Sintx Technologies shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

HeartBeam has a net margin of 0.00% compared to Sintx Technologies' net margin of -848.20%. HeartBeam's return on equity of 0.00% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
HeartBeamN/A N/A N/A
Sintx Technologies -848.20%-354.44%-115.37%

In the previous week, Sintx Technologies' average media sentiment score of 0.50 beat HeartBeam's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
HeartBeam Neutral
Sintx Technologies Positive

HeartBeam has higher earnings, but lower revenue than Sintx Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeartBeamN/AN/AN/AN/AN/A
Sintx Technologies$1.02M6.56-$10.36M-$4.91N/A

Sintx Technologies has a consensus target price of $9.33, indicating a potential upside of 502.15%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than HeartBeam.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HeartBeam
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Sintx Technologies beats HeartBeam on 7 of the 10 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

Export
MetricSintx TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$6.70M$5.88B$7.32B$12.82B
Dividend YieldN/A1.75%2.54%10.78%
P/E Ratio-0.3226.54272.9124.33
Price / Sales6.5670.76639.2097.25
Price / CashN/A33.7129.0336.90
Price / Book1.946.2211.386.42
Net Income-$10.36M$149.90M$3.47B$348.89M
7 Day Performance-5.49%1.12%2.16%0.51%
1 Month Performance10.71%9.16%7.59%4.84%
1 Year Performance-55.59%8.03%25.16%17.04%

Sintx Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SINT
Sintx Technologies
2.6148 of 5 stars		$1.55
flat		$9.33
+502.2%		-55.6%$6.70M$1.02MN/A40
DRTSW
Alpha Tau Medical
N/A$3.90
+8.0%		N/AN/A$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.04
+1.1%		N/AN/A$0.00$22.54MN/AN/A
COCHW
Envoy Medical
N/A$0.04
+39.9%		N/A-20.0%$0.00$207KN/A34
HSCSW
Heart Test Laboratories
N/A$0.08
+88.2%		N/A-72.0%$0.00$4.32KN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SINT) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Bank of America grew this stake 139%
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel